Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

Pirtobrutinib Maintenance After CAR-T Therapy in Relapsed or Refractory B-Cell Lymphoma

NCT07622784

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Not yet recruiting

Fixed Duration Treatment With Combined Pirtobrutinib and Short Course Immuno-chemotherapy in Fit Patients With Previously Untreated Symptomatic Chronic Lymphocytic Leukemia (CLL).

NCT07624799

Conditions: CLL (Chronic Lymphocytic Leukemia), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia

NCT07623655

Conditions: Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukaemia, Burkitt Lymphoma, +20 more
Locations: Not specified

View Trial Details

Not yet recruiting

Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging

NCT07624760

Conditions: AL Amyloidosis, Amyloidosis, Blood Protein Disorders, +23 more
Locations: University Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Not yet recruiting

Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma

NCT07615283

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Not yet recruiting

A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension

NCT07613216

Conditions: Behavior, Cardiovascular Diseases, Health Behavior, +24 more
Locations: Pulmonary Disease Clinic, Sentara Norfolk Hospital Norfolk, Virginia, United States

View Trial Details

Not yet recruiting

Identification of the Best Treatment Pathway for Patients With Relapsed/Refractory Lymphocytic B-derived Non-Hodgkin Lymphoma

NCT07614035

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: IRCCS Policlinico di Sant'Orsola Bologna, Emilia-Romagna, Italy

View Trial Details

Not yet recruiting

Phase I Study of FXS0683 in the Treatment of Blood Tumors

NCT07616089

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma, +18 more
Locations: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) Tianjin, Tianjin Municipality, China

View Trial Details

Not yet recruiting

Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma

NCT07611149

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

U96-CAR-T-Cells For R/R B-ALL

NCT07511426

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions